Neurotinib is a potent, selective allosteric inhibitor of the c-Abl kinase, investigated for its therapeutic potential in managing certain leukemias and solid tumors by reducing c-Abl phosphorylation and… Read more
Neurotinib is a potent, selective allosteric inhibitor of the c-Abl kinase, investigated for its therapeutic potential in managing certain leukemias and solid tumors by reducing c-Abl phosphorylation and inhibiting downstream CRKII activation. Laboratories rely on high-quality reference standards of the active pharmaceutical ingredient, alongside its related pharmacopeial and non-pharmacopeial impurities, to support rigorous analytical testing and method development. These compounds are essential for accurate impurity profiling and quantitative analysis throughout the drug development lifecycle. Additionally, researchers utilize stable isotope-labelled compounds as internal standards in mass spectrometry-based assays, ensuring precision when tracking drug metabolism and degradation pathways. By providing these critical materials, the category enables comprehensive quality control and validation, helping scientists maintain stringent regulatory standards for stability testing and the identification of potential degradation products during the research and manufacturing of kinase inhibitors.